These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
481 related articles for article (PubMed ID: 11849396)
1. Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency. Mackie FE; Meyer TW; Campbell DJ Kidney Int; 2002 Feb; 61(2):555-63. PubMed ID: 11849396 [TBL] [Abstract][Full Text] [Related]
2. Intrarenal angiotensin and bradykinin peptide levels in the remnant kidney model of renal insufficiency. Mackie FE; Campbell DJ; Meyer TW Kidney Int; 2001 Apr; 59(4):1458-65. PubMed ID: 11260408 [TBL] [Abstract][Full Text] [Related]
3. V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction. Perico N; Zoja C; Corna D; Rottoli D; Gaspari F; Haskell L; Remuzzi G Kidney Int; 2009 Nov; 76(9):960-7. PubMed ID: 19625993 [TBL] [Abstract][Full Text] [Related]
4. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation. Ots M; Mackenzie HS; Troy JL; Rennke HG; Brenner BM J Am Soc Nephrol; 1998 Feb; 9(2):224-30. PubMed ID: 9527398 [TBL] [Abstract][Full Text] [Related]
5. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure]. Ciechanowicz A Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor blockade improves renal function in rats with reduced renal mass. Pollock DM; Divish BJ; Polakowski JS; Opgenorth TJ J Pharmacol Exp Ther; 1993 Nov; 267(2):657-63. PubMed ID: 8246138 [TBL] [Abstract][Full Text] [Related]
7. Divergent regulation of circulating and intrarenal renin-angiotensin systems in response to long-term blockade. Kasper SO; Basso N; Kurnjek ML; Paglia N; Ferrario CM; Ferder LF; Diz DI Am J Nephrol; 2005; 25(4):335-41. PubMed ID: 15976496 [TBL] [Abstract][Full Text] [Related]
8. Hypertension and renal injury in experimental polycystic kidney disease. Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794 [TBL] [Abstract][Full Text] [Related]
9. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [TBL] [Abstract][Full Text] [Related]
10. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin. Lebel M; Rodrigue ME; Agharazii M; Larivière R Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776 [TBL] [Abstract][Full Text] [Related]
11. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
12. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? Gansevoort RT; de Zeeuw D; de Jong PE Kidney Int; 1994 Mar; 45(3):861-7. PubMed ID: 8196289 [TBL] [Abstract][Full Text] [Related]
13. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis. Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924 [TBL] [Abstract][Full Text] [Related]
14. Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan. Demeilliers B; Jover B; Mimran A J Hypertens; 1995 Dec; 13(12 Pt 2):1764-6. PubMed ID: 8903648 [TBL] [Abstract][Full Text] [Related]
15. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Andersen S; Tarnow L; Rossing P; Hansen BV; Parving HH Kidney Int; 2000 Feb; 57(2):601-6. PubMed ID: 10652037 [TBL] [Abstract][Full Text] [Related]
16. Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects? Kujal P; Chábová VČ; Vernerová Z; Walkowska A; Kompanowska-Jezierska E; Sadowski J; Vaňourková Z; Husková Z; Opočenský M; Skaroupková P; Schejbalová S; Kramer HJ; Rakušan D; Malý J; Netuka I; Vaněčková I; Kopkan L; Cervenka L Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1159-69. PubMed ID: 20880190 [TBL] [Abstract][Full Text] [Related]